Skinner Andrew M, Phillips S Tyler, Merrigan Michelle M, O'Leary Kevin J, Sambol Susan P, Siddiqui Farida, Peterson Lance R, Gerding Dale N, Johnson Stuart
Research Service, Edward Hines Jr., Veterans Affairs Hospital, Infectious Disease Section, Hines, IL 60141, USA.
Department of Medicine, Loyola University Medical Center, Chicago, IL 60153, USA.
J Clin Med. 2020 Dec 30;10(1):96. doi: 10.3390/jcm10010096.
Most pathogenic strains of possess two large molecular weight single unit toxins with four similar functional domains. The toxins disrupt the actin cytoskeleton of intestinal epithelial cells leading to loss of tight junctions, which ultimately manifests as diarrhea in the host. While initial studies of purified toxins in animal models pointed to toxin A (TcdA) as the main virulence factor, animal studies using isogenic mutants demonstrated that toxin B (TcdB) alone was sufficient to cause disease. In addition, the natural occurrence of TcdA-/TcdB+ (TcdA-/B+)mutant strains was shown to be responsible for cases of infection (CDI) with symptoms identical to CDI caused by fully toxigenic (A+/B+) strains. Identification of these cases was delayed during the period when clinical laboratories were using immunoassays that only detected TcdA (toxA EIA). Our hospital laboratory at the time performed culture as well as toxA EIA on patient stool samples. A total of 1.6% (23/1436) of all clinical isolates recovered over a 2.5-year period were TcdA-/B+ variants, the majority of which belonged to the restriction endonuclease analysis (REA) group CF and toxinotype VIII. Despite reports of serious disease due to TcdA-/B+ CF strains, these infections were typically mild, often not requiring specific treatment. While TcdB alone may be sufficient to cause disease, clinical evidence suggests that both toxins have a role in disease.
大多数致病菌株具有两种大分子量单单位毒素,带有四个相似的功能结构域。这些毒素破坏肠道上皮细胞的肌动蛋白细胞骨架,导致紧密连接丧失,最终在宿主体内表现为腹泻。虽然在动物模型中对纯化毒素的初步研究表明毒素A(TcdA)是主要毒力因子,但使用同基因突变体的动物研究表明,单独的毒素B(TcdB)就足以引发疾病。此外,已证明TcdA-/TcdB+(TcdA-/B+)突变菌株的自然出现是导致艰难梭菌感染(CDI)病例的原因,这些病例的症状与由完全产毒(A+/B+)菌株引起的CDI相同。在临床实验室使用仅检测TcdA(toxA酶免疫测定法)的免疫测定法期间,这些病例的识别被延迟。当时我们医院实验室对患者粪便样本进行培养以及toxA酶免疫测定。在2.5年期间回收的所有临床分离株中,共有1.6%(23/1436)是TcdA-/B+变体,其中大多数属于限制性内切酶分析(REA)组CF和毒素型VIII。尽管有报道称TcdA-/B+ CF菌株会导致严重疾病,但这些感染通常较轻,往往不需要特殊治疗。虽然单独的TcdB可能足以引发疾病,但临床证据表明两种毒素在疾病中都起作用。